Rare Diseases
Latest News
Lipedema: A potentially devastating, often unrecognized disease
“If patients with lipedema gain weight, the problem becomes even worse,” Dr. C. William Hanke said.
News
FDA approves levoketoconazole for Cushing syndrome
The drug, which inhibits cortisol synthesis, is seen as addressing an unmet need.
From the Journals
Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasis
“These case series confirm the rarity of both generalized pustular psoriasis and palmoplantar pustulosis ... and the lack of effective treatment...
From the Journals
Spesolimab speeds lesion clearance in generalized pustular psoriasis
Patients treated with intravenous spesolimab showed significant clearance, but also susceptibility to infections.
From the Journals
Prurigo nodularis has two disease endotypes, a cluster analysis shows
Black patients with PN appear more likely to have a distinct systemic inflammatory signature.
Latest News
New option for flares in pustular psoriasis
Spesolimab earns Priority Review status from the FDA for treatment of flares in generalized pustular psoriasis.
Latest News
Genomic screening of healthy newborns gets more popular
For now, the findings on the psychosocial effects of general newborn genomic screening show that “we should consider genetics to be just one more...
Conference Coverage
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
Conference Coverage
Drug combo at outset of polyarticular JIA benefits patients most
Despite the wariness that some families and even providers have about starting JIA therapy with both a biologic and conventional DMARD, new data...
Latest News
Expected spike in acute flaccid myelitis did not occur in 2020
COVID-19 interventions may have reduced transmission of the associated enteroviruses.
Conference Coverage
Evaluations of novel approaches to treating NF-1 tumors are underway
“We need a way to inhibit the cutaneous neurofibromatosis early in life and prevent disfigurement that occurs when kids become adults.”